By making Medtronic copyrighted materials available on this Website, Medtronic is granting healthcare professionals permission to use the materials for their personal use. Any use of such materials must be accompanied by the copyright notice © Medtronic, Inc. 2009 or as otherwise noted.
Use this presentation to educate prospective referring physicians about the impact of pain in cancer patients and the role of intrathecal drug delivery in managing this patient population.
This presentation includes information about the sutureless pump connector implant and technology.
Use these presentations to educate prospective referring physicians about Medtronic Pain Therapies. The presentations vary in length and content.
Chapter 1 - Patients who are mostly likely to benefit from intrathecal drug deliveryDr. David L. Caraway, MD, CEO & Medical Director, Center for Pain Relief, Tri-State St. Mary's Regional Medical Center, Huntington, WV speaks about patient selection. |
Chapter 2 - Managing pain with low dose morphineTolerance and hyperalgesia can occur in patients who are taking opioids. Learn how these issues are addressed with intrathecal low dosing. |
Chapter 3 - The intrathecal drug delivery screening trial reveals pain relief potentialA screening trial helps determine if pain relief goals can be met with intrathecal drug delivery. In this chapter, Dr. Caraway shares his screening trial strategy. |
Chapter 4 - Intrathecal drug delivery and post implant patient managementSetting patient expectations is critical to success with the therapy. Find out about key information that should be shared with patients to ensure they are properly prepared. |
Chapter 5 - Intrathecal drug delivery therapy goalsIt is important to talk candidly with patients about limitations brought on by pain and how a pump might help meet pain relief goals. Get guidance on this dialogue in this chapter. |
Chapter 6 - Pain practice managementIntrathecal drug delivery expands the pain relief tools available to physicians. Dr. Caraway shares how he manages refills, dosage changes and therapy discussions. |
Chapter 7 - Many benefits to working with MedtronicMedtronic offers a wide array of product and marketing support for pain. Learn about sales rep support, education and marketing tools, and safety updates. |
Chapter 8 - Medtronic's competitive advantageOnly Medtronic offers myPTM, a feature that gives patients control over their dosage within physician-set parameters. Dr. Caraway shares his experience with myPTM. |
Intrathecal Drug Delivery Therapy for Uncontrolled Cancer PainCancer and end-of-life patients often have high opioid requirements, resulting in significant side effects. Dr. Caraway talks about intrathecal drug delivery as an option to manage pain with minimal side effects. |
This animation shows how the drug is delivered to the spine.
This short video contains an overview of the bridge bolus programming procedure.
This video gives an overview of how to prep the pump for implant.
This video shows how to empty the SynchroMed II pump.
This video shows how to fill the SynchroMed II pump.
This video shows how to rinse the SynchroMed II pump.
This video shows how to refill the SynchroMed II pump.